business
AU & NZ ENTERPRISE PROFILES

Kazia Therapeutics Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: KZA

What does Kazia Therapeutics Limited do?

Kazia Therapeutics Limited is a locally owned publicly listed company, engaged in pharmaceutical research and development. The company operates in Australia, Hong Kong and The United States of America, and is administered from its head office in Sydney, New South Wales.

The company is listed on the Australian Securities Exchange under the code, KZA.

Kazia Therapeutics Limited - Products & Brands

Kazia Therapeutics Limited is an ASX listed oncology-focused biotechnology company. The company is engaged in the development and clinical trials of the following drug candidates:

  • Paxalisib – This drug candidate’s target indication is brain cancer.
  • EVT801 – This drug candidate’s target indication is liver and kidney cancer.

IBISWorld provides enterprise profiles on thousands of leading organizations across Australia and New Zealand.

LEARN MORE

Kazia Therapeutics Limited - Financial Statements

pie_chart Kazia Therapeutics Limited Financial Profit & Loss Account

BALANCE DATE6/30/20216/30/20206/30/20196/30/20186/30/2017
Sales Revenue15,183N/AN/AN/AN/A
Other Revenue0000000000000000000000000
Total Revenue0000000000000000000000000
Cost of Goods Sold0000000000000000000000000
Depreciation0000000000000000000000000
R & D Expenditure0000000000000000000000000
lock To view Kazia Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Kazia Therapeutics Limited - Financial Ratios

pie_chart Kazia Therapeutics Limited Financial Growth

BALANCE DATE6/30/20216/30/20206/30/20196/30/20186/30/2017
Total Revenue Growth1335.15-32.20-88.0648.75N/A
Sales Revenue Growth0000000000000000000000000
EBITDA0000000000000000000000000
NPAT0000000000000000000000000
Shareholder's Funds0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000

pie_chart Kazia Therapeutics Limited Financial Ratios

BALANCE DATE6/30/20216/30/20206/30/20196/30/20186/30/2017
Return on Revenue (ROR) (%)-55.3-1175.1-656.2-46.1-121.1
Return on Shareholders’ Funds (ROSF) (%)0000000000000000000000000
Return on Assets (ROA) (%)0000000000000000000000000
Profit Margin (%)0000000000000000000000000
Revenue per Employee ($’000 per person)0000000000000000000000000
AAAAAA AAAAAA0000000000000000000000000
lock To view Kazia Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Kazia Therapeutics Limited's Competitive Environment

Kazia Therapeutics Limited operates in the following industries:

Kazia Therapeutics Limited's main competitors:

  • WSP New Zealand Limited
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
  • AAAAAAAAAAAAA AAAAAAAAAAA AAAAA
lock To view Kazia Therapeutics Limited's full competitive environment, see report purchase options.
Purchase this report or a membership to unlock the full analysis of the capital intensity of this industry.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Company Profiles - table of contents

A high-level overview of Kazia Therapeutics Limited’s registered business details, a company synopsis, history and background, as well as Kazia Therapeutics Limited’s main brands and products.

We outline the Kazia Therapeutics Limited’s key personnel by position type and title.

Get a full view of Kazia Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Understand the main operating divisions of Kazia Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Kazia Therapeutics Limited operates in.

Understand the competitive threats and opportunities within the industries Kazia Therapeutics Limited operates in. Gain insight into the industry trends and competitive forces that Kazia Therapeutics Limited is exposed to.

We outline Kazia Therapeutics Limited’s ultimate parent and largest shareholders.

A list of Kazia Therapeutics Limited’s associated companies, holding company and trusts.

Where available, we provide details of Kazia Therapeutics Limited’s banker, external auditor, insurance broker, internal auditor, solicitor and telecommunication provider.

Purchase to Read Full Report

100% Money Back Guarantee Digicert Trusted

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Enterprise Financial Statements
  • Financial Ratios
    Financial Ratios
  • Industry Averages
    Industry Averages
  • Competitive Landscape
    Competitive Landscape
  • Key Enterprise Personnel
    Key Enterprise Personnel
  • Subsidiaries & Ownership Structure
    Subsidiaries & Ownership Structure

Why buy this enterprise profile on Kazia Therapeutics Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on Kazia Therapeutics Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal